Trial Profile
A phase I open-label, crossover study of GSP 301 nasal spray versus mometasone monotherapy in adult healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Feb 2017
Price :
$35
*
At a glance
- Drugs Mometasone/olopatadine (Primary) ; Mometasone
- Indications Allergic rhinitis
- Focus Pharmacokinetics
- 16 Feb 2017 New trial record